ATP10B variants in Parkinson’s disease: a large cohort study in Chinese mainland population-Reference-Cited by-同舟云学术

ATP10B variants in Parkinson’s disease: a large cohort study in Chinese mainland population

Published:2021-02-18 Issue:5 Volume:141 Page:805-806
ISSN:0001-6322
Container-title:Acta Neuropathologica
language:en
Short-container-title:Acta Neuropathol

Author:

Zhao Yuwen,Pan Hongxu,Wang Yige,Zeng Qian,Fang Zhenghuan,He Runcheng,Xu Kun,Zhou Xiaoxia,Zhou Xun,Zhou Zhou,Li Yanghong,Deng Penghui,Xu Yinghui,Xu Qian,Sun Qiying,Li Bin,Zhao Guihu,Lei Lifang,Zhang Hainan,Wang Chunyu,Tan Jieqiong,Yan Xinxiang,Shen Lu,Jiang Hong,Li Jinchen,Guo Jifeng,Tang Beisha,Liu Zhenhua

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00401-021-02280-9.pdf

Reference7 articles.

1. Li C, Ou R, Chen Y, Gu X, Wei Q, Cao B et al (2020) ATP10B and the risk for early-onset Parkinson’s disease. Mov Disord 35:2359–2360. https://doi.org/10.1002/mds.28285

2. Martin S, Smolders S, Van den Haute C, Heeman B, van Veen S, Crosiers D et al (2020) Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export. Acta Neuropathol 139:1001–1024. https://doi.org/10.1007/s00401-020-02145-7